Cite Filings / SPRO
Feed Companies Filings Check
Sign in

CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
Filings Insiders Search text
All 521 Financials 159 Shareholder Meetings 12 Executive Compensation 140 Insider Trading 231 Beneficial Ownership Interest 56 Business Combinations 121 Public Offerings 24 Mutual Funds and ETFs 9 Others 48
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-27
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-13
  4. DEF 14A Proxy Proxy Statement 2025-04-28
  5. DEF 14A Proxy Proxy Statement 2024-04-16
  6. DEF 14A Proxy Proxy Statement 2023-09-01
  7. PRE 14A Proxy Proxy Statement (Preliminary) 2023-08-22
  8. DEF 14A Proxy Proxy Statement 2022-08-05
  9. DEF 14A Proxy Proxy Statement 2021-07-06
  10. PRE 14A Proxy Proxy Statement (Preliminary) 2021-06-25
  11. DEF 14A Proxy Proxy Statement 2020-09-30
  12. DEF 14A Proxy Proxy Statement 2019-04-26
  13. DEF 14A Proxy Proxy Statement 2018-04-27

Page 1 of 1 · 12 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…